Your browser doesn't support javascript.
loading
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.
Lacaze, Paul; Bakshi, Andrew; Riaz, Moeen; Polekhina, Galina; Owen, Alice; Bhatia, Harpreet S; Natarajan, Pradeep; Wolfe, Rory; Beilin, Lawrence; Nicholls, Stephen J; Watts, Gerald F; McNeil, John J; Tonkin, Andrew M; Tsimikas, Sotirios.
Afiliação
  • Lacaze P; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Electronic address: paul.lacaze@monash.edu.
  • Bakshi A; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Riaz M; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Polekhina G; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Owen A; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Bhatia HS; Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Natarajan P; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA; Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical Scho
  • Wolfe R; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Beilin L; Medical School Royal Perth Hospital, University of Western Australia, Perth, Western Australia, Australia.
  • Nicholls SJ; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Monash Cardiovascular Research Centre, Victorian Heart Institute, Monash University, Clayton, Victoria, Australia.
  • Watts GF; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital, Victoria Square, Perth, Western Australia, Australia.
  • McNeil JJ; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Tonkin AM; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Tsimikas S; Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, La Jolla, California, USA.
J Am Coll Cardiol ; 80(14): 1287-1298, 2022 10 04.
Article em En | MEDLINE | ID: mdl-36175048
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Lipoproteína(a) Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Lipoproteína(a) Idioma: En Ano de publicação: 2022 Tipo de documento: Article